Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Diagnosis and treatment of heart disease: are women different from men?

Xhyheri B, Bugiardini R.

Prog Cardiovasc Dis. 2010 Nov-Dec;53(3):227-36. doi: 10.1016/j.pcad.2010.07.004. Review.

PMID:
21130920
[PubMed - indexed for MEDLINE]
2.

The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.

Hawkins NM, Scholes S, Bajekal M, Love H, O'Flaherty M, Raine R, Capewell S.

Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):208-16. doi: 10.1161/CIRCOUTCOMES.111.000058. Epub 2013 Mar 12.

PMID:
23481523
[PubMed - indexed for MEDLINE]
Free Article
3.

Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.

Lee HY, Cooke CE, Robertson TA.

J Manag Care Pharm. 2008 Apr;14(3):271-80.

PMID:
18439049
[PubMed - indexed for MEDLINE]
Free Article
4.

Drug secondary prevention in postmenopausal women with ischemic heart disease.

Zdrenghea D, Pop D, Sitar-Tăut A, Cebanu M, Zdrenghea V.

Rom J Intern Med. 2009;47(1):41-5.

PMID:
19886068
[PubMed - indexed for MEDLINE]
5.

Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.

Hippisley-Cox J, Coupland C.

BMJ. 2005 May 7;330(7499):1059-63. Erratum in: BMJ. 2006 Apr 15;332(7546):912.

PMID:
15879390
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).

Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D; TASPIC-CRO Study Group Investigators.

Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):646-54.

PMID:
16874158
[PubMed - indexed for MEDLINE]
7.

The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.

Høgh AL.

Dan Med J. 2012 Sep;59(9):B4514. Review.

PMID:
22951205
[PubMed - indexed for MEDLINE]
8.

Pharmacological approach to patients with non-ST segment elevation myocardial infarction: does sex make a difference?

Janion-Sadowska A, Sielski J, Gierlotka M, Nowalany-Kozielska E, Janion M, Poloński L.

Pol Arch Med Wewn. 2011 Jan-Feb;121(1-2):18-22.

PMID:
21346693
[PubMed - indexed for MEDLINE]
Free Article
9.

Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.

Vermeer NS, Bajorek BV.

J Clin Pharm Ther. 2008 Dec;33(6):591-601. doi: 10.1111/j.1365-2710.2008.00950.x.

PMID:
19138236
[PubMed - indexed for MEDLINE]
10.

[Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].

Pedrinelli R, Ciccone M, Novo S, Catapano AL.

G Ital Cardiol (Rome). 2012 Nov;13(11):734-40. doi: 10.1714/1168.12949. Review. Italian.

PMID:
23096582
[PubMed - indexed for MEDLINE]
11.

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.

Am J Med. 2004 Jul 15;117(2):73-81.

PMID:
15234641
[PubMed - indexed for MEDLINE]
12.
13.

Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.

Ramsay SE, Whincup PH, Lawlor DA, Papacosta O, Lennon LT, Thomas MC, Ebrahim S, Morris RW.

BMJ. 2006 Jan 21;332(7534):144-5. Epub 2006 Jan 9.

PMID:
16401630
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.

Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F; CPACS Investigators.

Am Heart J. 2009 Mar;157(3):509-516.e1. doi: 10.1016/j.ahj.2008.09.026. Epub 2008 Dec 17.

PMID:
19249422
[PubMed - indexed for MEDLINE]
15.

Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins.

Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS.

Gend Med. 2008 Mar;5(1):53-61.

PMID:
18420166
[PubMed - indexed for MEDLINE]
16.

Sex differences in percutaneous coronary interventions.

Lokhandwala JO, Skelding KA.

J Cardiovasc Transl Res. 2009 Sep;2(3):300-5. doi: 10.1007/s12265-009-9119-4. Epub 2009 Jul 15. Review.

PMID:
20560018
[PubMed - indexed for MEDLINE]
17.

Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.

Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA Jr; GRACE Investigators.

Int J Cardiol. 2007 Jun 25;119(1):65-72. Epub 2006 Oct 12.

PMID:
17045681
[PubMed - indexed for MEDLINE]
18.

Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.

Fisher M, Folland E.

Am J Ther. 2008 Mar-Apr;15(2):137-49. doi: 10.1097/MJT.0b013e31816a61bb. Review.

PMID:
18356634
[PubMed - indexed for MEDLINE]
19.

Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events.

Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, Fitzgerald G, Jackson EA, Eagle KA; Global Registry of Acute Coronary Events investigators.

Heart. 2009 Jan;95(1):20-6. doi: 10.1136/hrt.2007.138537. Epub 2008 May 7.

PMID:
18463200
[PubMed - indexed for MEDLINE]
20.

Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Feher G, Koltai K, Papp E, Alkonyi B, Solyom A, Kenyeres P, Kesmarky G, Czopf L, Toth K.

Drugs Aging. 2006;23(7):559-67.

PMID:
16930084
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk